An Encouraging Assessment of New Drugs for Myelofibrosis

patientpower has 2403 videos Subscribe Here

Description: The prospect of new myelofibrosis medicines and the recently released three-year data on ruxolitinib provided some evidence that even more patients can be treated successfully. Dr. Francisco Cervantes shares his perspective on new data about myelofibrosis drugs, their effectiveness, and how patients tend to respond. He shares his views with Andrew Schorr in an interview from the 2013 European Hematology Association meeting in Stockholm. Watch now.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 07/24/13
Added : 4 years ago
Category : General


Nothing found.